Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.

NCT01855945 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

627

Enrollment

INDUSTRY

Sponsor class

Conditions

Prophylaxis of A/H3N2v Influenza

Interventions

BIOLOGICAL: Swine Influenza

Sponsor

Novartis Vaccines